• Title

    Probing the mysteries of human health and disease.

  • Title Slide 2

    Vibrant biomedical research campus situated in the beautiful Sonoran Desert Ecosystem.

  • Student Slide

    Multidisciplinary program to train the next generation of biomedical scientists.

  • Title Slide 3

    Collaborative research environment harnessing leading-edge technology and training.

A multidisciplinary PhD program focused on outstanding scholarship in the fields of immunobiology, molecular biophysics, and cell biology

Home Page

Over 50 Faculty and 20 PhD Students

The Cellular and Molecular Medicine (CMM) and Immunobiology (IMB) graduate programs have merged to create a new PhD program called the Graduate Program in MOLECULAR MEDICINE (GPMM). The GPMM at the University of Arizona is an interdepartmental, multidisciplinary training program fosters the development of scientists and educators who are prepared for lifelong participation in research and other intellectual pursuits. With an emphasis on bridging basic and translational science, Molecular Medicine students receive advanced training in the theory and practice of biomedical science. There are opportunities to investigate human health and disease ranging from biophysical studies at the atomic level, to modeling critical cellular process in tractable systems, to clinical research. The exposure and skills that students acquire prepare them for careers in biomedical research (including academia and the biotechnology industry), science education, journalism, and public policy.

Cell Biology

Cell Biology

To provide students with a foundation for understanding the cellular underpinnings of human health and disease, while advancing the field through hands-on, cutting-edge research.

Medical Biophysics

Medical Biophysics

Apply quantitative multi-disciplinary approaches to molecular and integrative biology with a goal to understand the biophysical basis of health and disease mechanisms, identify drugable targets and contribute to Precision Medicine.

Immunobiology

Immunobiology

Advance the insights into the rules of engagement that determine the outcome of host-pathogen interactions to develop future therapies for infectious, autoimmune and malignant diseases.

News

Congratulations to Dr. Noel Warfel

Congratulations to Dr. Noel Warfel who was awarded a Lung Cancer Discovery Award, a one year $100,000 grant from the American Lung Association to fund his project “Targeting PIM kinases to Oppose Nrf2-driven Lung Cancers”


In the Age of Social Media, He's a New Kind of Scientist

What does it mean to be a scientist? Far more than doing research in a lab, says Michael Johnson, whose unconventional passage into the field began with a bowling championship and a music degree.


Romanoski Lab discovers DNA variations that may underlie susceptibility to coronary artery disease.

In a recent study led by UA Assistant Professor Casey Romanoski, PhD, the research team used genome-wide epigenetics to identify major drivers of human artery endothelial cell responses to inflammatory environments. They utilized endothelial genome sequences called enhancers to pinpoint DNA variation in humans that may underpin differential susceptibility to coronary artery disease. Their findings, published June 6th in eLIFE (https://elifesciences.org/articles/22536), improve our understanding of vascular biology and moves us one step closer to understanding the molecular mechanisms of disease.